Pricing Log in Create free account

Aytu BioPharma, Inc. (AYTU) vs Optimi Health Corp. (OPTH)

Aytu BioPharma, Inc. and Optimi Health Corp. are both Drug Manufacturers Specialty & Generic companies. Aytu BioPharma, Inc. is the larger, with a market value of $19.7M against $13.7M — 1.4× the size. Across the 8 metrics below, Aytu BioPharma, Inc. leads on 6 and Optimi Health Corp. on 2.

Valuation

Metric AYTU OPTH Drug Manufacturers Specialty & Generic median
P/E n/m — 20.55
P/S 0.39 n/m 2.08
P/B 0.64 2.86 1.79
Price to free cash flow 6.97 n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 0.23 n/m 2.87
Earnings yield (74.86%) — (15.94%)
Free cash flow yield 14.35% (66.34%) 0.00%

Profitability

Metric AYTU OPTH Drug Manufacturers Specialty & Generic median
Gross margin 63.95% — 53.51%
Operating margin (14.44%) — 0.00%
Net margin (24.76%) — (2.45%)
Free cash flow margin 5.62% 0.00% 0.00%
Return on equity (52.55%) — (0.80%)
Return on assets (12.44%) — (1.67%)
Return on invested capital (19.99%) 0.00% 0.00%

Growth

Metric AYTU OPTH Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (13.27%) — 5.22%
EPS growth (last fiscal year) 46.30% (1,575.96%) 42.91%
Revenue growth, 5-year CAGR (2.59%) — 7.24%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric AYTU OPTH Drug Manufacturers Specialty & Generic median
Debt to equity 0.48 1.02 0.04
Current ratio 1.13 0.06 2.41
Net debt to EBITDA 2.17 (0.67) 1.01

Dividend

Metric AYTU OPTH Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric AYTU OPTH Drug Manufacturers Specialty & Generic median
Market cap 19.67m 13.69m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack